Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Armand

Showing results (191-200 of 240) with videos related to

Pageof 24
Sort By:
Anti-Cancer Drugs|February 1, 1996
Phase I and pharmacology study of intoplicine (RP 60475; NSC 645008), novel topoisomerase I and II inhibitor, in cancer patientsD Abigerges, J P Armand, G G Chabot, et al.
American Journal of Clinical Oncology|April 1, 1993
Phase II trials of tetrahydropyranyl-adriamycin (Pirarubicin) on renal and colon carcinoma, melanoma, and soft tissue sarcomaH Roché, N Guiochet, P Kerbrat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2002
Pharmacokinetic study of cystemustine, administered on a weekly schedule in cancer patientsE Cellarier, C Terret, P Labarre, et al.
British Journal of Cancer|August 19, 2010
A phase I, dose-finding study of sunitinib in combination with irinotecan in patients with advanced solid tumoursE Boven, C Massard, J P Armand, et al.
Anticancer Research|July 1, 1987
Mitoxantrone combined with vincristine, cyclophosphamide and fluorouracil for advanced breast cancer. A study of short-term response rateJ L Misset, R Metz, M Gil-Delgado, et al.
International Journal of Cancer|May 15, 1994
Correlation between p53 gene expression and tumor-cell proliferation in oropharyngeal cancerJ Bourhis, J Bosq, G D Wilson, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Phase II study of oxaliplatin in poor-prognosis non-small cell lung cancer (NSCLC). ATTIT. Association pour le Traitement des Tumeurs Intra ThoraciquesI Monnet, S Brienza, F Hugret, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1984
An EORTC phase II study of mitoxantrone in solid tumors and lymphomasR De Jager, P Cappelaere, J P Armand, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Phase I/II trial of continuous infusion vinorelbine for advanced breast cancerC Toussaint, J Izzo, M Spielmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003
Dose-dense regimen of temozolomide given every other week in patients with primary central nervous system tumorsK Vera, L Djafari, S Faivre, et al.
Pageof 24

Showing results (191-200 of 240) with videos related to

Sort By:
Pageof 24
Anti-Cancer Drugs|February 1, 1996
Phase I and pharmacology study of intoplicine (RP 60475; NSC 645008), novel topoisomerase I and II inhibitor, in cancer patientsD Abigerges, J P Armand, G G Chabot, et al.
American Journal of Clinical Oncology|April 1, 1993
Phase II trials of tetrahydropyranyl-adriamycin (Pirarubicin) on renal and colon carcinoma, melanoma, and soft tissue sarcomaH Roché, N Guiochet, P Kerbrat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2002
Pharmacokinetic study of cystemustine, administered on a weekly schedule in cancer patientsE Cellarier, C Terret, P Labarre, et al.
British Journal of Cancer|August 19, 2010
A phase I, dose-finding study of sunitinib in combination with irinotecan in patients with advanced solid tumoursE Boven, C Massard, J P Armand, et al.
Anticancer Research|July 1, 1987
Mitoxantrone combined with vincristine, cyclophosphamide and fluorouracil for advanced breast cancer. A study of short-term response rateJ L Misset, R Metz, M Gil-Delgado, et al.
International Journal of Cancer|May 15, 1994
Correlation between p53 gene expression and tumor-cell proliferation in oropharyngeal cancerJ Bourhis, J Bosq, G D Wilson, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Phase II study of oxaliplatin in poor-prognosis non-small cell lung cancer (NSCLC). ATTIT. Association pour le Traitement des Tumeurs Intra ThoraciquesI Monnet, S Brienza, F Hugret, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1984
An EORTC phase II study of mitoxantrone in solid tumors and lymphomasR De Jager, P Cappelaere, J P Armand, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Phase I/II trial of continuous infusion vinorelbine for advanced breast cancerC Toussaint, J Izzo, M Spielmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003
Dose-dense regimen of temozolomide given every other week in patients with primary central nervous system tumorsK Vera, L Djafari, S Faivre, et al.
Pageof 24